Usefulness of D-dimer as a Predictor of High-risk Patients for Early Invasive Treatment and Early Death in Non-ST Elevation Acute Coronary Syndrome Patients.
- Author:
Sung Mo CHOI
1
;
June Ho NA
;
Ki Ho LEE
;
Kyeong Ryong LEE
;
Dae Young HONG
;
Kwang Je BAEK
;
Sang Min PARK
;
Sang O PARK
Author Information
1. Department of Emergency Medicine, School of Medicine, Konkuk University Konkuk University Hospital, Seoul, Republic of Korea. empso@kuh.ac.kr
- Publication Type:Original Article
- Keywords:
D-dimer;
Acute coronary syndrome;
Percutaneous coronary intervention
- MeSH:
Acute Coronary Syndrome*;
Area Under Curve;
Electrocardiography;
Electronic Health Records;
Emergency Service, Hospital;
Heart Failure;
Hemodynamics;
Humans;
Mortality;
Percutaneous Coronary Intervention;
Plasma;
Retrospective Studies;
Sensitivity and Specificity;
Tachycardia, Ventricular;
Thorax
- From:Journal of the Korean Society of Emergency Medicine
2014;25(6):756-763
- CountryRepublic of Korea
- Language:Korean
-
Abstract:
PURPOSE: The aim of the study is to evaluate the efficacy of initial plasma D-dimer levels measured in the emergency department (ED) in prediction of early 28-day mortality and high-risk patients for early invasive treatment in patients with Non-ST elevation acute coronary syndrome (NST-ACS). METHODS: This is a retrospective clinical study of NST-ACS patients in the ED. All patients were managed according to the 2010 ACLS guidelines. EKG, cardiac markers, and D-dimer were analyzed. All data were collected via electronic medical records. The two major endpoints were 28-day mortality and high-risk patients who were defined as cases with one of the following: refractory ischemic chest discomfort, recurrent/persistent ST deviation, ventricular tachycardia, hemodynamic instability, and signs of heart failure. We assessed the relationship between initial D-dimer levels, and high-risk patients, and 28-day mortality. RESULTS: A total of 390 patients were analyzed. There were 25 high-risk patients (6.41%) and 10 non-survival cases (2.56%). The median (inter-quartile ranges) D-dimer value was higher in high-risk patients than in non-high risk patients (1.36 [0.57 to 2.30] vs. 0.31 [0.23 to 0.53] ug/dL; p<0.0001). Area under curve (AUC) in Receiver-operatory characteristic (ROC) curve for D-dimer in high-risk patients was 0.834 (95% confidence interval: 0.750-0.920) with the optimum cutoff value of 0.475ug/dL with a sensitivity of 84% and a specificity of 71%. The median value of D-dimer in non-survival cases was higher than in survival cases (1.17 [0.84 to 18.46] vs. 0.33 [0.23 to 0.56] ug/dL; p<0.0001). AUC for D-dimer in predicting 28-day mortality was 0.837 (95% CI: 0.710-0.964) with the optimum cutoff value of 0.98 ug/dL with a sensitivity of 80.0% and a specificity of 86.3%. CONCLUSION: The D-dimer level in the initial state might be helpful in predicting high-risk patients for early invasive treatment or 28-day mortality in patients with NST-ACS in the ED.
